Bisphosphonates and Breast Cancer Cell Survival
Author Information
Author(s): Fromigue O, Kheddoumi N, Body J-J
Primary Institution: Institut Jules Bordet, Université Libre de Bruxelles
Hypothesis
Can bisphosphonates inhibit the protective effects of bone-derived growth factors on breast cancer cell survival?
Conclusion
Bisphosphonates can reduce the stimulatory effects of growth factors on breast cancer cell survival.
Supporting Evidence
- Bisphosphonates reduced the skeletal morbidity rate in breast cancer patients with bone metastases by up to 40-50%.
- Bisphosphonates can induce human breast cancer cell death in vitro.
- Growth factors like IGF-I and FGF-2 promote breast cancer cell survival.
Takeaway
This study shows that certain drugs called bisphosphonates can help fight breast cancer by stopping the cancer cells from using helpful substances in the bone that help them grow.
Methodology
The study used MTT tests to assess cell viability and caspase activity to evaluate apoptosis in breast cancer cell lines treated with bisphosphonates and growth factors.
Limitations
The exact concentrations of bisphosphonates in vivo are difficult to determine, and the study primarily focused on in vitro conditions.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website